LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹26 Cr | ₹51 Cr | ₹73 Cr | ₹73 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹30 Cr |
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹73 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | 14.67 | |
| Mar2025 | ₹26 Cr | -48.85 | |
| Mar2024 | ₹51 Cr | -30.63 | |
| Mar2023 | ₹73 Cr | 0.66 | |
| Mar2022 | ₹73 Cr | - | |
Compare Total Non-Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹269.3 Cr | 3.3% | 20% | -26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 3.3% |
20% |
-26.6% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses